Quantexa considers UK or US IPO
Analysis based on 8 articles · First reported Aug 18, 2026 · Last updated Aug 18, 2026
The potential IPO could provide a significant liquidity event for Quantexa's investors and boost the company's valuation, while a US listing would further weaken London's position as a listing venue. The stake sale by Warburg Pincus may signal investor sentiment and could affect Quantexa's perceived market value.
British AI company Quantexa is considering a multibillion-dollar stock market listing in Britain or the United States, according to CEO Vishal Marria. The company has been 'IPO-ready' since January but has not decided on timing and could remain privately held. A US listing would further dent London's stock market, which has seen a string of companies opt for US exchanges. Marria noted the US offers a deeper pool of capital and potential for higher valuation. Meanwhile, minority shareholder Warburg Pincus is working with adviser Citigroup to explore options for its 9-10% stake, including a possible sale, with an auction expected later this year. Quantexa was valued at about $2.6 billion last year after a $175 million Series F round led by Teachers Venture Growth. The company also announced a £175 million contract with United Kingdom — HM Revenue and Customs and is competing for the NHS's single patient record programme.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard